Astrocytic atrophy as a pathological feature of Parkinson’s disease with LRRK2 mutation
Abstract The principal hallmark of Parkinson’s disease (PD) is the selective neurodegeneration of dopaminergic neurones. Mounting evidence suggests that astrocytes may contribute to dopaminergic neurodegeneration through decreased homoeostatic support and deficient neuroprotection. In this study, we...
Guardado en:
Autores principales: | Paula Ramos-Gonzalez, Susana Mato, Juan Carlos Chara, Alexei Verkhratsky, Carlos Matute, Fabio Cavaliere |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6caf315b9ef544218a6118c4473e1b8b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Systemic Inflammation and Astrocyte Reactivity in the Neuropsychiatric Sequelae of COVID-19: Focus on Autism Spectrum Disorders
por: Marta Valenza, et al.
Publicado: (2021) -
LRRK2 levels in immune cells are increased in Parkinson’s disease
por: D. A. Cook, et al.
Publicado: (2017) -
Transcriptome analysis in LRRK2 and idiopathic Parkinson’s disease at different glucose levels
por: Rubén Fernández-Santiago, et al.
Publicado: (2021) -
Is LRRK2 the missing link between inflammatory bowel disease and Parkinson’s disease?
por: Mary K. Herrick, et al.
Publicado: (2021) -
LRRK2 inhibitors and their potential in the treatment of Parkinson’s disease: current perspectives
por: Atashrazm F, et al.
Publicado: (2016)